What is Nano Nuclear Energy's reimbursement allowance?

Nano Nuclear Energy (NNE) reported reimbursement allowance of $15K in Q3 2025.

What does reimbursement allowance mean?

This represents a reserve or allowance established to account for expected reimbursements from third parties for costs incurred by the company. It serves as a contra-asset or adjustment to expenses, reflecting the anticipated recovery of specific expenditures. This metric helps investors evaluate the company's ability to manage cost-sharing arrangements and recover project-related investments.

Nano Nuclear Energy NNE Reimbursement Allowance

Reimbursement Allowance at other companies

Surgery Partners, Inc.SGRY

$8.6M-10.4%

VestisVSTS

$25K-97.8%

Hilton Grand VacationsHGV

$149M+12.0%

BlackSky TechnologyBKSY

$7.46M—

Huron Consulting GroupHURN

$8.06M-4.6%

Coastal FinancialCCB

$2.39M+133%

Other financials

Income statement

See full

Net income-$9.2M+56.9%

EPS (diluted)-$0.18+68.4%

Balance sheet

See full

Cash & equivalents$197.7M+66.7%

Total debt$2.6M-8.7%

Total equity$595.9M+351%

Total assets$603.9M+335%

Cash flow

See full

Operating cash flow-$5.3M-121%

CapEx$4.6M+994%

Free cash flow-$9.6M-276%

Valuation

See full

Market cap$1.21B-22.0%

Enterprise value$1.01B-29.3%

Returns & leverage

See full

Return on equity-8.6%-3.9pp

Debt / equity0×0.0×

Current ratio95.7×+68.5×

Where this comes from

Reported directly by Nano Nuclear Energy in its filing.

Tagged under the XBRL concept NNE:ReimbursementAllowance.

The official record: Nano Nuclear Energy’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nano Nuclear Energy's reimbursement allowance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nano Nuclear Energy's reimbursement allowance?: Nano Nuclear Energy (NNE) reported reimbursement allowance of $15K in Q3 2025.
What does reimbursement allowance mean?: This represents a reserve or allowance established to account for expected reimbursements from third parties for costs incurred by the company. It serves as a contra-asset or adjustment to expenses, reflecting the anticipated recovery of specific expenditures. This metric helps investors evaluate the company's ability to manage cost-sharing arrangements and recover project-related investments.